Lantheus Holdings, Inc.
Revenue Breakdown
| Fiscal Year | PYLARIFY | DEFINITY | TechneLite | Other Radiopharmaceutical Products | Strategic Partnerships and Other Revenue |
|---|---|---|---|---|---|
| FY2015 | $0 | $114.4M | $105.7M | $70.7M | $3.0M |
| FY2016 | $0 | $132.0M | $101.8M | $69.4M | $3.2M |
| FY2017 | $0 | $152.8M | $100.5M | $74.9M | $3.2M |
| FY2018 | $0 | $171.8M | $95.8M | $72.6M | $3.1M |
| FY2019 | $0 | $182.8M | $96.4M | $65.2M | $3.0M |
| FY2020 | $0 | $178.1M | $85.8M | $71.9M | $3.4M |
| FY2021 | $92.5M | $234.4M | $85.0M | $10.2M | $3.0M |
| FY2022 | $527.4M | $245.2M | $83.8M | $63.7M | $15.4M |
| FY2023 | $851.8M | $278.9M | $88.3M | $67.0M | $110.9M |
| FY2024 | $983.2M | $299.7M | $106.8M | $74.3M | $133.1M |